These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1686248)
1. Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes. Singh K; Tripp SL; Dunton AW; Douglas FL; Rakhit A Drug Metab Dispos; 1991; 19(5):990-6. PubMed ID: 1686248 [TBL] [Abstract][Full Text] [Related]
2. Alteration of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat. Chindavijak B; Belpaire FM; De Smet F; Bogaert MG J Pharmacol Exp Ther; 1988 Sep; 246(3):1075-9. PubMed ID: 3418510 [TBL] [Abstract][Full Text] [Related]
3. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. Witherow LE; Houston JB J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760 [TBL] [Abstract][Full Text] [Related]
5. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs. Siebert GA; Hung DY; Chang P; Roberts MS J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005 [TBL] [Abstract][Full Text] [Related]
6. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood. Terao N; Shen DD J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018 [TBL] [Abstract][Full Text] [Related]
7. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist. Imawaka H; Sugiyama Y J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854 [TBL] [Abstract][Full Text] [Related]
8. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum. Shibata Y; Takahashi H; Ishii Y Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592 [TBL] [Abstract][Full Text] [Related]
9. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Obach RS Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025 [TBL] [Abstract][Full Text] [Related]
10. Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance. Hallifax D; Houston JB Drug Metab Dispos; 2006 Nov; 34(11):1829-36. PubMed ID: 16882765 [TBL] [Abstract][Full Text] [Related]
11. Estimations of intestinal and liver first-pass metabolism in vivo. Studies on gentisamide conjugation in the rat. Hirayama H; Morgado J; Gasinska I; Pang KS Drug Metab Dispos; 1990; 18(5):588-94. PubMed ID: 1981706 [TBL] [Abstract][Full Text] [Related]
12. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver. Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552 [TBL] [Abstract][Full Text] [Related]
13. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. Rane A; Wilkinson GR; Shand DG J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445 [TBL] [Abstract][Full Text] [Related]
14. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity. Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943 [TBL] [Abstract][Full Text] [Related]
15. Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes. Lam JL; Benet LZ Drug Metab Dispos; 2004 Nov; 32(11):1311-6. PubMed ID: 15483198 [TBL] [Abstract][Full Text] [Related]
16. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat. Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179 [TBL] [Abstract][Full Text] [Related]
17. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver. Pang KS; Sherman IA; Schwab AJ; Geng W; Barker F; Dlugosz JA; Cuerrier G; Goresky CA Hepatology; 1994 Sep; 20(3):672-83. PubMed ID: 8076925 [TBL] [Abstract][Full Text] [Related]
18. On the antipyrine test in laboratory animals. Studies in the dog and monkey. Vickers FF; Bowman TA; Dvorchik BH; Passananti GT; Hughes DM; Vesell ES Drug Metab Dispos; 1989; 17(2):160-5. PubMed ID: 2565205 [TBL] [Abstract][Full Text] [Related]
19. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513 [TBL] [Abstract][Full Text] [Related]
20. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake. Baker M; Parton T Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]